BIO IMED

BIO IMED develops two devices: DomotIA, a remote IoT home-care system for patient monitoring with sensors, cloud computing and web/mobile apps for doctors and patients; and BiopIA, a device that automates liquid biopsy by combining microfiltration, microfluidic chips, precision sensors, an optical system and AI software, claiming 100% cell recovery and analysis times reduced to less than a tenth compared with human assessment. Founders: Simone Pennini (CEO) with Prof. Agostino Accardo (CSO); team includes Diego Sardon (Sales Director, former CEO of Prodigys Technology and Bilimetrix), Carlo Moretto (CIO), Pierpaolo Pupa (COO) and Alessandro Pellegrino (CTO). Diagnostic accuracy of around 90% in clinical trials; POR FESR funding with eligible expenditure of 56,500 euros and a grant of 39,550 euros; first prize for Healthcare Innovation at CLab Trieste, special prize at AIIC Healthcare Innovation 2019. Partners: Cattinara Hospital in Trieste and the Italian Liver Foundation; a European patent prior-art search is underway. Covered by Corriere (Nuvola), AboutPharma and Panorama Sanita. Based in Trieste.